Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Weight Loss Predicts Inferior Outcome in Polycythemia Vera Patients

Albert Jang, MD, Hussein Hamad, MD, Sarvari Venkata Yellapragada, MD, Iberia R. Sosa, MD PhD, Gustavo A. Rivero, MD

Blood (2020) 136 (Supplement 1): 22–23.

https://doi.org/10.1182/blood-2020-134801

Published: 2020

Journal Articles

Elderly Hemopoietic and Inflammatory Signature for Life-Threatening COVID-19 Infection

Jesus Romero, Jorge Mazzini, MD, Sarvari Venkata Yellapragada, MD, Iberia R. Sosa, MD PhD, Gustavo A. Rivero, MD

Blood (2020) 136 (Supplement 1): 36–37.

https://doi.org/10.1182/blood-2020-141466

Published: 2020

Journal Articles

With Equal Access, African Americans with Non-del17p Multiple Myeloma Have Superior Overall Survival, but del17p Still Carries Poor Prognosis across Race: A VA Study

Anusha Munjuluri, MSc, Nathanael Fillmore, PhD, Diana Cirstea, MD, Hassan Yameen, MD, Sarvari Venkata Yellapragada, MD, Ifeorah Chizoba, MPH, Nhan Do, MD, Mary Brophy, MD MPH, Nikhil C. Munshi, MD

Blood (2019) 134 (Supplement_1): 4388.

https://doi.org/10.1182/blood-2019-131247

Published: 2019

Journal Articles

Evaluating Mean Corpuscular Volume As Predictor for Erythropoiesis Stimulating Agent Response in Elderly Patients Diagnosed with Myelodysplasia

Joshua P Muniz, MD, Sarvari Venkata Yellapragada, MD, Gustavo A. Rivero, MD

Blood (2019) 134 (Supplement_1): 5420.

https://doi.org/10.1182/blood-2019-131458

Published: 2019

Journal Articles

Protein Phase Separation in Hematopoietic Stem Cell Aging

Laure Maneix, PhD, Polina Iakova, M.S., Shannon Moree, B.A., Melanie Sweeney, B.A., Nagaishwarya Moka, MD, Sarvari Venkata Yellapragada, MD, Andre Catic, MD PhD

Blood (2019) 134 (Supplement_1): 5003.

https://doi.org/10.1182/blood-2019-124092

Published: 2019

Journal Articles

Differential Induction Among Younger Patients Diagnosed with Secondary Acute Myelogenous Leukemia Is Feasible By Cytogenetic/Molecular Risk Stratification

Aimaz Afrough, MD, Rafee Talukder, MD, Sarvari Venkata Yellapragada, MD, Purnima Sravanti Teegavarapu, MD, Martha P. Mims, MD PhD, Gustavo A. Rivero, MD

Blood (2019) 134 (Supplement_1): 2678.

https://doi.org/10.1182/blood-2019-129183

Published: 2019

Journal Articles

Incidence of Second Primary Malignancies and Association with Treatment in US Veterans with Multiple Myeloma

Nathanael Fillmore, PhD, Sarvari Venkata Yellapragada, MD, Cenk Yildirim, MS, Aimaz Afrough, MD, Adanma Anji Ayanambakkam Attanathi, MD, Ifeorah Chizoba, MPH, Nhan Do, MD, Mary Brophy, MD MPH, Nikhil C. Munshi, MD

Blood (2019) 134 (Supplement_1): 1806.

https://doi.org/10.1182/blood-2019-132227

Published: 2019

Journal Articles

Predictive Factors for Complete Remission and Survival in AML Patients Failing to Achieve Adequate Bone Marrow Day 14 Blast Eradication

Rafee Talukder, MD, Sarvari Venkata Yellapragada, MD, Hussein Hamad, MD, Gustavo A. Rivero, MD

Blood (2018) 132 (Supplement 1): 1464.

https://doi.org/10.1182/blood-2018-99-115830

Published: 2018

Journal Articles

Vitamin D Deficiency Predicts for Poor Overall Survival in Caucasian but Not African American Patients with Multiple Myeloma

Sarvari Venkata Yellapragada, MD, Anna Frolov, M.S., M.A, Nathanael Fillmore, PhD, Pallavi Dev, Sumaira Shafi, MD, Ifeorah Chizoba, MPH, Do Nhan, MD, Do T Nhan, MD, Nikhil Munshi, MD

Blood (2018) 132 (Supplement 1): 1890.

https://doi.org/10.1182/blood-2018-99-117268

Published: 2018

Journal Articles

With Equal Access and Utilization of Resources,Younger African American Patients Have Superior Survival Compared to Caucasian Patients Diagnosed with Multiple Myeloma at the Veterans Affairs Hospitals

Nathanael Fillmore, PhD, Sarvari Venkata Yellapragada, MD, Mehmet Kemal Samur, PhD, Gustavo A. Rivero, MD, Saiju Pyarajan, PhD, Nhan Do, MD, Mary Brophy, MD MPH, Nikhil Munshi, MD

Blood (2018) 132 (Supplement 1): 3191.

https://doi.org/10.1182/blood-2018-99-119490

Published: 2018

Journal Articles

Traceable Red Cell Distribution Width Modifications Are Observed Prior to MDS Diagnosis and Primarily Associated with Cardiovascular Organ Dysfunction

Claudia Rodriguez, MD,, Alcedo Pedro, Sarvari Venkata Yellapragada, MD, Martha P. Mims, MD PhD, Gustavo A. Rivero, MD

Blood (2016) 128 (22): 5537.

https://doi.org/10.1182/blood.V128.22.5537.5537

Published: 2016

Journal Articles

Survival Improvement in Myelodysplastic Syndrome with Refractory Anemia after Treatment with Selective-Serotonin-Reuptake-Inhibitors

Gabriela Sanchez, MD, Ang Li, MD, Sarvari Venkata Yellapragada, MD, Martha P. Mims, Anna Frolov, Effie Rahman, Gustavo A. Rivero, MD

Blood (2014) 124 (21): 5621.

https://doi.org/10.1182/blood.V124.21.5621.5621

Published: 2014

Journal Articles

Time Dependent Platelet Attrition Identifies Biological Subgroup In Intermediate But Not Low-Risk Myelodysplastic Syndrome (MDS) Revised-IPSS (R-IPSS) Exhibiting Distinct Overall Survival

Gustavo A. Rivero, MD, Maria Otazo, Sarvari Venkata Yellapragada, MD, Ang Li, Matthew Zheng, Ruben Hernandez Perez, Martha Mims, MD

Blood (2013) 122 (21): 5233.

https://doi.org/10.1182/blood.V122.21.5233.5233

Published: 2013

Journal Articles

The Impact Of The Establishment Of a Hematology Telemedicine Consult Service In a Referral Center On Patients’ Travel Distance, Travel Cost and Satisfaction Scores

Sarvari Venkata Yellapragada, MD, Jesus Hermosillo-Rodriguez, MD, Yvonne Sada, MD, Annette Walder, M.S., Kathy Sam, MD, Alka Mulchandani, MD, Teresa G Hayes, M.D., Davila A Jessica, Ph.D.

Blood (2013) 122 (21): 5601.

https://doi.org/10.1182/blood.V122.21.5601.5601

Published: 2013

Journal Articles

Sustained Erythroid Response Associated With Red Cell Transfusion and Progressive Growth Factor Independence Is Feasible With Adjuvant Sertraline In Low-Risk Myelodysplastic Syndrome (LR-MDS)

Rui Li, MD, PhD, Matthew Zheng, Sarvari Venkata Yellapragada, MD, Ruben Hernandez Perez, Martha Mims, MD, Gustavo A. Rivero, MD

Blood (2013) 122 (21): 5235.

https://doi.org/10.1182/blood.V122.21.5235.5235

Published: 2013

Journal Articles

Selective-Serotonin-Reuptake-Inhibitors (SSRIs) In Combination With Myeloma Directed Therapy Accelerates Sentinel M-Protein Normalization In De-Novo Multiple Myeloma

Mathew Zheng, Sarvari Venkata Yellapragada, MD, Martha Mims, MD, Ruben Hernandez Perez, Gustavo A. Rivero, MD

Blood (2013) 122 (21): 5387.

https://doi.org/10.1182/blood.V122.21.5387.5387

Published: 2013

Journal Articles

Significant Improvement in Overall Survival Among Patients Diagnosed with Low-Risk Myelodysplastic Syndrome (MDS) Treated with Selective-Serotonin-Reuptake-Inhibitors (SSRIs)

Ang Li, Sarvari Venkata Yellapragada, MD, Martha Mims, MD, Gustavo A. Rivero, MD

Blood (2012) 120 (21): 3818.

https://doi.org/10.1182/blood.V120.21.3818.3818

Published: 2012

Journal Articles

Outcome of Myelodysplastic Syndrome in Veterans Treated with 5-Azacitidine and Decitabine

Kanza S Abbas, MD, Ang Li, Gustavo A. Rivero, MD, Premal D Lulla, MD, Alka Mulchandani, Zahida Yasin, MD, Sarvari Venkata Yellapragada, MD

Blood (2011) 118 (21): 5055.

https://doi.org/10.1182/blood.V118.21.5055.5055

Published: 2011

Journal Articles

8p11–12 Myeloprolferative Syndrome: A Case Report and Brief Review of the Literature

Sarvari Venkata Yellapragada, MD, Martha P. Mims, MD, PhD, Courtney Jackson, MD, Mark Lewis, MD, Mark M. Udden, MD

Blood (2008) 112 (11): 5260.

https://doi.org/10.1182/blood.V112.11.5260.5260

Published: 2008

NARROW

Weight Loss Predicts Inferior Outcome in Polycythemia Vera Patients

Elderly Hemopoietic and Inflammatory Signature for Life-Threatening COVID-19 Infection

With Equal Access, African Americans with Non-del17p Multiple Myeloma Have Superior Overall Survival, but del17p Still Carries Poor Prognosis across Race: A VA Study

Evaluating Mean Corpuscular Volume As Predictor for Erythropoiesis Stimulating Agent Response in Elderly Patients Diagnosed with Myelodysplasia

Protein Phase Separation in Hematopoietic Stem Cell Aging

Differential Induction Among Younger Patients Diagnosed with Secondary Acute Myelogenous Leukemia Is Feasible By Cytogenetic/Molecular Risk Stratification

Incidence of Second Primary Malignancies and Association with Treatment in US Veterans with Multiple Myeloma

Predictive Factors for Complete Remission and Survival in AML Patients Failing to Achieve Adequate Bone Marrow Day 14 Blast Eradication

Vitamin D Deficiency Predicts for Poor Overall Survival in Caucasian but Not African American Patients with Multiple Myeloma

With Equal Access and Utilization of Resources,Younger African American Patients Have Superior Survival Compared to Caucasian Patients Diagnosed with Multiple Myeloma at the Veterans Affairs Hospitals

Traceable Red Cell Distribution Width Modifications Are Observed Prior to MDS Diagnosis and Primarily Associated with Cardiovascular Organ Dysfunction

Survival Improvement in Myelodysplastic Syndrome with Refractory Anemia after Treatment with Selective-Serotonin-Reuptake-Inhibitors

Time Dependent Platelet Attrition Identifies Biological Subgroup In Intermediate But Not Low-Risk Myelodysplastic Syndrome (MDS) Revised-IPSS (R-IPSS) Exhibiting Distinct Overall Survival

The Impact Of The Establishment Of a Hematology Telemedicine Consult Service In a Referral Center On Patients’ Travel Distance, Travel Cost and Satisfaction Scores

Sustained Erythroid Response Associated With Red Cell Transfusion and Progressive Growth Factor Independence Is Feasible With Adjuvant Sertraline In Low-Risk Myelodysplastic Syndrome (LR-MDS)

Selective-Serotonin-Reuptake-Inhibitors (SSRIs) In Combination With Myeloma Directed Therapy Accelerates Sentinel M-Protein Normalization In De-Novo Multiple Myeloma

Significant Improvement in Overall Survival Among Patients Diagnosed with Low-Risk Myelodysplastic Syndrome (MDS) Treated with Selective-Serotonin-Reuptake-Inhibitors (SSRIs)

Outcome of Myelodysplastic Syndrome in Veterans Treated with 5-Azacitidine and Decitabine

8p11–12 Myeloprolferative Syndrome: A Case Report and Brief Review of the Literature

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only